(Date:5/9/2008)... Face Detection, Enhanced Standards Support and Ja...NIUS, Lithuania, May 7 /PRNewswire/ -- Neurotechno...ification technologies, today announced,the availa...of large-scale,automated fingerprint identificatio...int identification systems. MegaMatcher 2.1 includ...
(Date:5/9/2008)...aches law enforcement agents, supports CFCE traini...ching, SOUTHFIELD, Mich., May 9 /PRNewswire/ -- T...oday that it will be lending Ed Moore, one of,its ...ng to become,Certified Forensics Computer Examiner... with the CCF for 3 years, will lend his 8 years o...
(Date:5/9/2008)...ology is more important for predicting biodiversit... issue of the journal Nature challenges current th... for predicting how climate change or human activi...rticle, an international group of researchers demo...a river system can be accurately predicted with a ...
(Date:5/9/2008)...chers have invented a method for turning simple da... assessments of fish biodiversity, allowing better...he ecological impact of man-made structures like d...o can be used to model and predict a wide range of...rne illnesses to vegetation patterns on land adjac...
Breaking Biology News(10 mins):Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 2Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 3Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems 4Center for Computer Forensics Offers Expert to Volunteer as CFCE Certification Applicants Coach 2Biodiversity -- it's in the water 2Rainfall and river networks prove accurate predictors of fish biodiversity 2Rainfall and river networks prove accurate predictors of fish biodiversity 3Rainfall and river networks prove accurate predictors of fish biodiversity 4Challenge Spreadable Butter Now Features Marteks lifesDHA 28TM 29 2992 1Challenge Spreadable Butter Now Features Marteks lifesDHA 28TM 29 2992 2Challenge Spreadable Butter Now Features Marteks lifesDHA 28TM 29 2992 3CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology 2989 1CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology 2989 2CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology 2989 3Toy Magnets Can be a Very Real Threat 10939 1Toy Magnets Can be a Very Real Threat 10939 2Toy Magnets Can be a Very Real Threat 10939 32009 Bush budget a disaster for HIV AIDS 10936 12009 Bush budget a disaster for HIV AIDS 10936 2...enter and engineers at UT Arlington have collabora...e key to delivering on the promise of surgery with...the developmental stage, allows for magnetically m...to the abdominal cavity through the bellybutton or... the new instruments and determine just how to mov...
...ssive flow of DNA sequence information will gather... the 2nd Annual U.S. Department of Energy Joint Ge...the world,s only user facility dedicated to making...erse research community and individual investigato...esource to advance the frontiers of their discipli...
...of Antimicrobial Chemotherapy1 provides the best a...ile infection (CDI)---one of the most common and i...an be reduced in hospital wards if doctors prescri...pectrum agents. , Researchers at the Royal Free H...tes of any teaching hospital in the UK, investigat...
...le of carbon dioxide once it,s transported to the ...d of sinking, carbon dioxide is often consumed by ... zone," a dimly lit area 100 to 1,000 meters below...es the deep ocean, where it can be stored and prev...ouse gas, the oceans may have little impact on cha...
Other Biology News:Magnetic system could be key to surgery without scars 2Reminding doctors which antibiotics to prescribe cuts C. difficile infection rates 2Reminding doctors which antibiotics to prescribe cuts C. difficile infection rates 3Reminding doctors which antibiotics to prescribe cuts C. difficile infection rates 4Ocean's 'twilight zone' may be a key to understanding climate change 2(Date:5/12/2008)...RNewswire-FirstCall/ -- Alexza,Pharmaceuticals, In...ts for,its fiscal quarter ended March 31, 2008 and... its product candidates. The net loss for the 2008...ith accounting principles,generally accepted in th...d,to a net loss of $10.9 million in the comparable...
(Date:5/12/2008)...der Round of Financing for $3 Million, PITTSBURGH...s of,RedPath Integrated Pathology, Inc.,s PathFind...location into new, state-of-the-art headquarters,i...force which now totals,50, up from 20 a year ago. ... that it has closed an insider round of financing ...
(Date:5/12/2008)...c biotech business experience -, CAMBRIDGE, Mass....ation,(Nasdaq: VRNM ), a pioneer in the developme...performance specialty enzymes, today announced the...ors. The Company also,announced that Geoffrey Hazl...as resigned for personal reasons effective May 31,...
(Date:5/12/2008)...n to be Webcast -, MONTVALE, N.J., May 12 /PRNews...ex: SYI ) announced today that Noah Berkowitz, M.... Synvista will present at the upcoming Rodman,& Re...onday, May 19, 2008,at 12:10 p.m. CEST (6:10 a.m. ...at the Le Meridien Beach Plaza Hotel in Monte Carl...
Breaking Biology Technology:Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 2Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 3Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 4Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 5Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 6Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 7Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 8Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 9Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 10Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis 2Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis 3Verenium Appoints John F. Dee to Board of Directors 2Verenium Appoints John F. Dee to Board of Directors 3Verenium Appoints John F. Dee to Board of Directors 4Verenium Appoints John F. Dee to Board of Directors 5Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 2Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference 3...rified deoxynucleotides for optimal , resul...pplications, , , , Unsurpassed...! , Produce sensitive and consistent result...y-nucleotides from RAS. Improve performance and se...when analyzing low copy number targets., , ...
..., , Michaela Scigelova, Gary Woffendin; The... Malcolm Ward, Helen Byers; Proteome Sciences, L...chiatry KCL, London, UK., , , , ,... , , , The data presented here can be...eries ion trap mass spectrometer., , , ...
..., , Mark R. Kagan 1 , Julian Phillips 2 , ,...innigan, Piscataway, NJ; , 2Thermo Finnigan..., Andover, MA , , Chemical Struct...n be acquired using the Thermo Finnigan LCQ Series... , Introduction , , With ...
..., , David Barnidge , Leo E. Bonilla , Gar...cs, Inc., Minneapolis, MN , Thermo Finnigan... , ICAT Analysis , , , , ..., ProteomeX integrated proteomics workstation... , , , , , The differential ...
Other Biology Technology:PCR Grade Deoxynucleotides 2PCR Grade Deoxynucleotides 3PCR Grade Deoxynucleotides 4PCR Grade Deoxynucleotides 5Detection and Identification of Phosphorylation Sites in Proteins Using , LC/MS/MS with Neutral Fragment Loss Mapping 2Detection and Identification of Phosphorylation Sites in Proteins Using , LC/MS/MS with Neutral Fragment Loss Mapping 3Detection and Identification of Phosphorylation Sites in Proteins Using , LC/MS/MS with Neutral Fragment Loss Mapping 4Detection and Identification of Phosphorylation Sites in Proteins Using , LC/MS/MS with Neutral Fragment Loss Mapping 5Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using , an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier , Software Package 2Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using , an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier , Software Package 3Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using , an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier , Software Package 4Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using , an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier , Software Package 5Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using , an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier , Software Package 6Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using , an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier , Software Package 7Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using , an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier , Software Package 8Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using , an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier , Software Package 9Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 2Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 3Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 4Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 5Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 6Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 7COMING SOON: Anti-Mouse CD205 (DEC-205),Clone NLDC-145, mAb
DNA fragmentation factor & Inhibitor of CAD
Rabbit polyclonal to ErbB 2 ( Abpromise for all tested applications). entrezGeneID: 2064 SwissProtID: P04626
Component in MasterPure Purification Kits
Biology Products: